The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Open accessAbstract
Mitochondrial metabolism provides precursors to build macromolecules in growing cancer cells. In normally functioning tumour cell mitochondria, oxidative metabolism of glucose- and glutamine-derived carbon produces citrate and acetyl-coenzyme A for lipid synthesis, which is required for tumorigenesis. Yet some tumours harbour mutations in the citric acid cycle (CAC) or electron transport chain (ETC) that disable normal oxidative mitochondrial function, and it is unknown how cells from such tumours generate precursors for macromolecular synthesis. Here we show that tumour cells with defective mitochondria use glutamine-dependent reductive carboxylation rather than oxidative metabolism as the major pathway of citrate formation. This pathway uses mitochondrial and cytosolic isoforms of NADP(+)/NADPH-dependent isocitrate dehydrogenase, and subsequent metabolism of glutamine-derived citrate provides both the acetyl-coenzyme A for lipid synthesis and the four-carbon intermediates needed to produce the remaining CAC metabolites and related macromolecular precursors. This reductive, glutamine-dependent pathway is the dominant mode of metabolism in rapidly growing malignant cells containing mutations in complex I or complex III of the ETC, in patient-derived renal carcinoma cells with mutations in fumarate hydratase, and in cells with normal mitochondria subjected to acute pharmacological ETC inhibition. Our findings reveal the novel induction of a versatile glutamine-dependent pathway that reverses many of the reactions of the canonical CAC, supports tumour cell growth, and explains how cells generate pools of CAC intermediates in the face of impaired mitochondrial metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [630]
In the citing paper
“In the context of constitutive HIF-2α stabilization75 or a defective mitochondrial electron transport chain76, glutamine-derived α-KG is reductively carboxylated through the consumption of NADPH by IDH2 to generate citrate.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [76]
In the citing paper
“Previous reports showed that reductive carboxylation is a critical pathway to support the growth of tumor cells under hypoxia (Metallo, 2012; Mullen, 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Mullen, 2012
In the citing paper
“The upregulation of the reductive carboxylation pathway enhances cancer cells proliferation (Metallo, 2012; Mullen, 2012; Wise et al., 2011).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Mullen, 2012
In the citing paper
“For example, under conditions of hypoxia or impaired mitochondrial respiration, certain reactions of the TCA cycle reverse to support glutamine-dependent reductive carboxylation (92, 122, 123).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [123]
In the citing paper
“Citrate is generated by citrate synthase (CS) or through the reduction of α-ketoglutarate by isocitrate dehydrogenase (IDH).79–81”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [80]
In the citing paper
“Glutamine can contribute carbon to fatty acid synthesis via reductive carboxylation or oxidative glutaminolysis.”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Mullen et al., 2012
In the citing paper
“The former pathway is highly active in cells proliferating under hypoxia or those with a compromised respiratory chain (Metallo et al., 2012; Mullen et al., 2012; Scott et al., 2011; Wise et al., 2011), while the latter pathway has been observed in B cell lymphoma (Le et al., 2012).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Mullen et al., 2012
In the citing paper
“Although oxidation of glutamine-derived α-KG in the TCA cycle serves as a minor source of lipogenic acetyl-CoA under normal growth conditions, α-KG can be converted to citrate through reductive carboxylation under conditions of stress such as hypoxia or mitochondrial dysfunction (70–72).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [70]
In the citing paper
“In place of oxidative metabolism of both glucose and glutamine, these cancers preferentially perform reductive and carboxylating biosynthetic reactions from glutamine carbon (Le et al., 2012; Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Mullen et al., 2012
In the citing paper
“Recently three independent reports implicated IDH-dependent reductive carboxylation as playing a particularly important role in proliferating cells that exhibit decreased flux of glucose-derived pyruvate into the mitochondria. This occurs in hypoxic cells or in cells harboring defects in mitochondrial oxidative phosphorylation (Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Mullen et al., 2012
In the citing paper
“tumor cells with mutations in the TCA cycle or ETC (Mullen et al., 2011), or with hypoxia-induced suppression of oxidative metabolism (Metallo et al., 2011; Scott et al., 2011; Wise et al., 2011) use reductive carboxylation of α-KG to produce citrate and other precursors during growth.”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Mullen et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Branched tricarboxylic acid metabolism in Plasmodium falciparum
Olszewski, K. L., Mather, M. W., Morrisey, J. M., Garcia, B. A., Vaidya, A. B., Rabinowitz, J. D., & Llinás, M. (2010) · Nature · doi:10.1038/nature09301 · Cited by 124
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Self-citationGao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742
Self-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Self-citation
Flagged first, then by citations
1 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 1,000
Metabolic changes in cancer cells upon suppression of MYC
Ansó, E., Mullen, A. R., Felsher, D. W., Matés, J. M., DeBerardinis, R. J., & Chandel, N. S. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-7 · Cited by 64
Self-citationLam, H. C., Baglini, C. V., Lope, A. L., Parkhitko, A. A., Liu, H.-J., Alesi, N., Malinowska, I. A., Ebrahimi‐Fakhari, D., Saffari, A., Yu, J. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2458 · Cited by 63
Jakob, C. G., Upadhyay, A. K., Donner, P. L., Nicholl, E., Addo, S. N., Qiu, W., Ling, C., Gopalakrishnan, S. M., Torrent, M., Cepa, S. P., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00305 · Cited by 62
Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
Yu, X., Ma, R., Wu, Y., Zhai, Y., & Li, S. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00394 · Cited by 64
Control of the Antitumor Immune Response by Cancer Metabolism
Domblides, C., Lartigue, L., & Faustin, B. (2019) · Cells · doi:10.3390/cells8020104 · Cited by 64
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
Crispo, F., Condelli, V., Lepore, S., Notarangelo, T., Sgambato, A., Esposito, F., Maddalena, F., & Landriscina, M. (2019) · Cells · doi:10.3390/cells8080798 · Cited by 63
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
Wert, K. J., Velez, G., Vijayalakshmi, K., Shankar, V., Evans, L. P., Sengillo, J. D., Zare, R. N., Bassuk, A. G., Tsang, S. H., & Mahajan, V. B. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102636 · Cited by 62
Totten, S. P., Im, Y. K., Cañedo, E. C., Najyb, O., Nguyen, A., Hébert, S., Ahn, R., Lewis, K., Lebeau, B., Selva, R. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23396-2 · Cited by 63
NaCT/SLC13A5 facilitates citrate import and metabolism under nutrient-limited conditions
Kumar, A., Cordes, T., Thalacker‐Mercer, A. E., Pajor, A. M., Murphy, A. N., & Metallo, C. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109701 · Cited by 60
Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy
Chen, C., Wang, Z., & Qin, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935536 · Cited by 62
Identification of purine biosynthesis as an NADH-sensing pathway to mediate energy stress
Yang, R., Yang, C., Ma, L., Zhao, Y., Guo, Z., Niu, J., Chu, Q., Ma, Y., & Li, B. (2022) · Nature Communications · doi:10.1038/s41467-022-34850-0 · Cited by 60
Sciacovelli, M., Dugourd, A. J. F., Valcárcel-Jiménez, L., Yang, M. H., Nikitopoulou, E., Costa, A. S. H., Tronci, L., Caraffini, V., Rodrigues, P., Schmidt, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35036-4 · Cited by 62
NADH reductive stress drives metabolic reprogramming
Yang, R., Guo, Z., & Li, B. (2025) · Trends in Cell Biology · doi:10.1016/j.tcb.2025.07.005 · Cited by 61
Corbet, C., & Féron, O. (2015) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000178 · Cited by 61
Liu, J., Zheng, L., Wu, N., Ma, L., Zhong, J., Liu, G., & Lin, X. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf500622p · Cited by 60
Benjamin, D. I., Li, D. S., Lowe, W. L., Heuer, T. S., Kemble, G. W., & Nomura, D. K. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00240 · Cited by 60
Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism
Dong, J., Xiao, D., Zhao, Z., Ren, P., Li, C., Hu, Y., Shi, J., Su, H., Wang, L., Liu, H., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.59 · Cited by 61
Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122537 · Cited by 61
Mitochondria and Hypoxia: Metabolic Crosstalk in Cell-Fate Decisions
Bargiela, D., Burr, S. P., & Chinnery, P. F. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.02.002 · Cited by 60
Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
Hvinden, I. C., Cadoux-Hudson, T. A. D., Schofield, C. J., & McCullagh, J. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100469 · Cited by 63
Metabolic dependencies and targets in ovarian cancer
Zhang, Y., Wang, Y., Zhao, G., Oršulić, S., & Matei, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108413 · Cited by 65
Dynamic single-cell metabolomics reveals cell-cell interaction between tumor cells and macrophages
Zhang, Y., Shi, M., Li, M., Qin, S., Miao, D., & Bai, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-59878-w · Cited by 60
Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells
Rajagopalan, K. N., Egnatchik, R. A., Calvaruso, M. A., Wasti, A., Padanad, M. S., Boroughs, L. K., Ko, B., Hensley, C. T., Acar, M., Hu, Z., et al. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0134-4 · Cited by 61
Self-citationSun, Y., Bandi, M. L., Lofton, T. E., Smith, M. G., Bristow, C. A., Carugo, A., Rogers, N. E., Leonard, P. G., Chang, Q., Mullinax, R. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.043 · Cited by 60
Sun, W., Luan, S., Qi, C., Tong, Q., Yan, S., Li, H., & Zhang, Y. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0425-4 · Cited by 59
Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance
Nwosu, Z. C., Piorońska, W., Battello, N., Zimmer, A. D., Dewidar, B., Han, M., Pereira, S., Blagojevic, B., Castven, D., Charlestin, V., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102699 · Cited by 61
Mitochondria orchestrate macrophage effector functions in atherosclerosis
Dumont, A., Lee, M., Barouillet, T., Murphy, A. J., & Yvan‐Charvet, L. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100922 · Cited by 60
Benyahia, Z., Blackman, M. C. N. M., Hamelin, L., Zampieri, L. X., Capelôa, T., Bedin, M., Vazeille, T., Schakman, O., & Sonveaux, P. (2021) · Cancers · doi:10.3390/cancers13030569 · Cited by 58
The one-carbon pool controls mitochondrial energy metabolism via complex I and iron-sulfur clusters
Rosenberger, F. A., Moore, D., Atanassov, I., Moedas, M. F., Clemente, P., Végvári, Á., Fissi, N. E., Filograna, R., Bucher, A.-L., Hinze, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf0717 · Cited by 58
Botman, D., Tigchelaar, W., & Noorden, C. J. F. V. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414549071 · Cited by 58
Mitochondrial pyruvate carrier function and cancer metabolism
Rauckhorst, A. J., & Taylor, E. B. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.05.003 · Cited by 59
Mitochondrial metabolism and energy sensing in tumor progression
Iommarini, L., Ghelli, A. M., Gasparre, G., & Porcelli, A. M. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.006 · Cited by 58
Frizzell, N., Thomas, S., Carson, J. A., & Baynes, J. (2012) · Biochemical Journal · doi:10.1042/bj20112142 · Cited by 59
Metabolic reprogramming as a feast for virus replication
Polčicová, K., Baďurová, L., & Tomášková, J. (2020) · Acta Virologica · doi:10.4149/av_2020_210 · Cited by 57
Altea-Manzano, P., Vandekeere, A., Edwards-Hicks, J., Roldan, M., Abraham, E., Lleshi, X., Guerrieri, A. N., Berardi, D., Wills, J., Junior, J. M., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.10.005 · Cited by 57
FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer
Wilde, B. R., Chakraborty, N., Matulionis, N., Hernandez, S., Ueno, D., Gee, M. E., Esplin, E. D., Ouyang, K., Nykamp, K., Shuch, B. M., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0874 · Cited by 57
The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy
Wu, J., Liu, N., Chen, J., Tao, Q., Li, Q., Li, J., Chen, X., & Peng, C. (2024) · Research · doi:10.34133/research.0351 · Cited by 57
Inhibition of ATP Citrate Lyase Induces an Anticancer Effect via Reactive Oxygen Species
Migita, T., Okabe, S., Ikeda, K., Igarashi, S., Sugawara, S., Tomida, A., Taguchi, R., Soga, T., & Seimiya, H. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.048 · Cited by 58
Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
Le, A., Rajeshkumar, N. V., Maitra, A., & Dang, C. V. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0041 · Cited by 57
Bueno, M. J., Jimenez-Renard, V., Samino, S., Capellades, J., Junza, A., López-Rodríguez, M. L., Garcı́a-Cárceles, J., López-Fabuel, I., Bolaños, J. P., Chandel, N. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13028-1 · Cited by 57
Self-citationDessai, A. S., Domínguez, M. P., Chen, U.-I., Hasper, J., Prechtl, C., Yu, C. R., Katsuta, E., Dai, T., Zhu, B., Jung, S. Y., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1708 · Cited by 59
Breathless cancer cells get fat on glutamine
Anastasiou, D., & Cantley, L. C. (2012) · Cell Research · doi:10.1038/cr.2012.5 · Cited by 56
Citric Acid Cycle Intermediates in Cardioprotection
Czibik, G., Steeples, V., Yavari, A., & Ashrafian, H. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000220 · Cited by 58
Inhibiting both proline biosynthesis and lipogenesis synergistically suppresses tumor growth
Liu, M., Wang, Y., Yang, C., Ruan, Y., Bai, C., Chu, Q., Cui, Y., Chen, C., Ying, G., & Li, B. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191226 · Cited by 57
Glutamine metabolism in Th17/Treg cell fate: applications in Th17 cell-associated diseases
Yang, G., Xia, Y., & Ren, W. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1703-2 · Cited by 55
Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance
Chun, K., Kim, D., & Surh, Y. (2021) · Cells · doi:10.3390/cells10040758 · Cited by 56
Kaushik, A., Tarangelo, A., Boroughs, L. K., Ragavan, M., Zhang, Y., Wu, C., Li, X., Ahumada, K., Chiang, J., Tcheuyap, V. T., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp8293 · Cited by 56
Self-citationRethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 57
Changing appetites: the adaptive advantages of fuel choice
Stanley, I. A., Ribeiro, S. M., Giménez-Cassina, A., Norberg, E., & Danial, N. N. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.010 · Cited by 57
Targeting Metabolic Changes in Cancer: Novel Therapeutic Approaches
Bobrovnikova-Marjon, E. V., & Hurov, J. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-092012-112344 · Cited by 56
13C Isotope-Assisted Methods for Quantifying Glutamine Metabolism in Cancer Cells
Zhang, J., Ahn, W. S., Gameiro, P. A., Keibler, M. A., Zhang, Z., & Stephanopoulos, G. N. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00019-4 · Cited by 55
Metabolic scavenging by cancer cells: when the going gets tough, the tough keep eating
Michalopoulou, E., Bulusu, V., & Kamphorst, J. J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.256 · Cited by 59
The why and how of amino acid analytics in cancer diagnostics and therapy
Manig, F., Kuhne, K., von Neubeck, C., Schwarzenbolz, U., Yu, Z., Kessler, B. M., Pietzsch, J., & Kunz‐Schughart, L. A. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.12.001 · Cited by 55
Lane, A. N., Tan, J. D., Wang, Y., Yan, J., Higashi, R. M., & Fan, T. W. ‐. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.01.010 · Cited by 55
The metabolic axis of macrophage and immune cell polarization
Hobson-Gutierrez, S., & Carmona‐Fontaine, C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034462 · Cited by 57
Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation
Lee, J., Lee, H., Lee, S., Kang, J. H., Lee, S.-H., Kim, S., Cho, E. S., Kim, N. H., Yook, J. I., & Kim, S. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.036 · Cited by 55
Metabolic alterations in hereditary and sporadic renal cell carcinoma
Coffey, N. J., & Simon, M. C. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00800-2 · Cited by 56
Worth, A. J., Basu, S. S., Snyder, N. W., Mesaros, C., & Blair, I. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.591354 · Cited by 54
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
Läsche, M., Emons, G., & Gründker, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00409 · Cited by 55
Sánchez‐González, C., Nuevo‐Tapioles, C., Martín, J. C. H., Pereira, M. P., Sanz, S. S., de Molina, A. R., Cuezva, J. M., & Formentini, L. (2020) · The EMBO Journal · doi:10.15252/embj.2019103812 · Cited by 55
Singleton, D. C., Dechaume, A.-L., Murray, P. M., Katt, W. P., Baguley, B. C., & Leung, E. Y. (2020) · BMC Cancer · doi:10.1186/s12885-020-06885-3 · Cited by 56
13 C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8 T cells
Ma, E. H., Dahabieh, M. S., DeCamp, L. M., Kaymak, I., Kitchen-Goosen, S. M., Oswald, B. M., Longo, J., Roy, D. G., Verway, M. J., Johnson, R. M., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj1431 · Cited by 53
Common Responses of Tumors and Wounds to Hypoxia
Payen, V. L., Brisson, L., Dewhirst, M. W., & Sonveaux, P. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000098 · Cited by 55
Intratumoral heterogeneity in kidney cancer
Ricketts, C. J., & Linehan, W. M. (2014) · Nature Genetics · doi:10.1038/ng.2904 · Cited by 56
Self-citationD’Alessandro, A., Amelio, I., Berkers, C. R., Antonov, A., Vousden, K. H., Melino, G., & Zolla, L. (2014) · Oncotarget · doi:10.18632/oncotarget.2300 · Cited by 54
Metabolic control of DNA methylation in naive pluripotent cells
Betto, R. M., Diamante, L., Perrera, V., Audano, M., Rapelli, S., Lauria, A., Incarnato, D., Arboit, M., Pedretti, S., Rigoni, G., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00770-2 · Cited by 55
AMPK targets PDZD8 to trigger carbon source shift from glucose to glutamine
Li, M., Wang, Y., Wei, X., Cai, W.-F., Wu, J., Zhu, M., Wang, Y., Liu, Y., Xiong, J., Qu, Q., et al. (2024) · Cell Research · doi:10.1038/s41422-024-00985-6 · Cited by 52
Mamer, O., Gravel, S., Choinière, L., Chénard, V., St‐Pierre, J., & Avizonis, D. Z. (2013) · Metabolomics · doi:10.1007/s11306-013-0521-1 · Cited by 52
Laxman, S., Sutter, B. M., Shi, L., & Tu, B. P. (2014) · Science Signaling · doi:10.1126/scisignal.2005948 · Cited by 55
Glutamine metabolism in cancer therapy
Nguyen, T.-L., & Durán, R. V. (2018) · Cancer Drug Resistance · doi:10.20517/cdr.2018.08 · Cited by 56
Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy
Bergaggio, E., & Piva, R. (2019) · Cancers · doi:10.3390/cancers11040563 · Cited by 52
Abooshahab, R., Hooshmand, K., Razavi, S. A., Gholami, M., Sanoie, M., & Hedayati, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00385 · Cited by 52
Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential
Wagner, A., Kosnacova, H., Chovanec, M., & Jurkovičová, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147897 · Cited by 54
The immunometabolic ecosystem in cancer
Bantug, G. R., & Hess, C. (2023) · Nature Immunology · doi:10.1038/s41590-023-01675-y · Cited by 53
A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism
Mazzon, M., Castro, C., Roberts, L. D., Griffin, J. L., & Smith, G. L. (2014) · Journal of General Virology · doi:10.1099/vir.0.069591-0 · Cited by 53
Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
Chakraborty, P. K., Xiong, X., Mustafi, S. B., Saha, S., Dhanasekaran, D. N., Mandal, N. A., McMeekin, S., Bhattacharya, R., & Mukherjee, P. (2015) · Oncotarget · doi:10.18632/oncotarget.5424 · Cited by 51
Siegel, D. J., Permentier, H. P., Reijngoud, D., & Bischoff, R. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.11.022 · Cited by 51
NMR-based Stable Isotope Resolved Metabolomics in systems biochemistry
Lane, A. N., & Fan, T. W. ‐. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.02.009 · Cited by 54
The regulation of shrimp metabolism by the white spot syndrome virus (WSSV)
Kumar, R., Huang, J., Ng, Y. S., Chen, C.-Y., & Wang, H. (2021) · Reviews in Aquaculture · doi:10.1111/raq.12643 · Cited by 50
Exploring metabolic pathways that contribute to the stem cell phenotype
Vacanti, N. M., & Metallo, C. M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.007 · Cited by 51
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk
Morandi, A., Giannoni, E., & Chiarugi, P. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.11.001 · Cited by 50
Montal, E. D., Bhalla, K., Dewi, R. E., Ruiz, C. F., Haley, J. D., Ropell, A. E., Gordon, C. R., Haley, J. D., & Girnun, G. D. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0199-6 · Cited by 52
Cook, K. M., Shen, H. M., McKelvey, K. J., Gee, H. E., & Hau, E. K. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147265 · Cited by 55
Acetyl-CoA and Metabolite Fluxes Regulate White Adipose Tissue Expansion
Felix, J. B., Cox, A. R., & Hartig, S. M. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.008 · Cited by 52
Extracellular citrate and metabolic adaptations of cancer cells
Parkinson, E. K., Adamski, J., Zahn, G., Gaumann, A. K. A., Flores‐Borja, F., Ziegler, C. M., & Mycielska, M. E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10007-1 · Cited by 50
Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme
Esteban-Amo, M. J., Jiménez-Cuadrado, P., Serrano‐Lorenzo, P., de la Fuente, M. Á., & Simarro, M. (2024) · Biomedicines · doi:10.3390/biomedicines12092050 · Cited by 51
Lipid metabolism in cancer: Exploring phospholipids as potential biomarkers
Delmas, D., Mialhe, A., Cotte, A. K., Connat, J., Bouyer, F., Hermetet, F., & Aires, V. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118095 · Cited by 49
Hypoxia and Metabolism in Cancer
Bensaad, K., & Harris, A. L. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_1 · Cited by 49
Eleftheriadis, T., Pissas, G., Antoniadi, G., Spanoulis, A., Liakopoulos, V., & Stefanidis, I. (2014) · International Immunology · doi:10.1093/intimm/dxu077 · Cited by 50
NMR and MS-based Stable Isotope-Resolved Metabolomics and applications in cancer metabolism
Lane, A. N., Higashi, R. M., & Fan, T. W. ‐. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.11.020 · Cited by 52
Transporters at the Interface between Cytosolic and Mitochondrial Amino Acid Metabolism
Hewton, K. G., Johal, A. S., & Parker, S. J. (2021) · Metabolites · doi:10.3390/metabo11020112 · Cited by 52
Cell energy metabolism and bone formation
Sautchuk, R., & Eliseev, R. A. (2022) · Bone Reports · doi:10.1016/j.bonr.2022.101594 · Cited by 51
Metabolic pathways utilized by the porcine conceptus, uterus, and placenta
Johnson, G. A., Seo, H., Bazer, F. W., Wu, G., Kramer, A. C., McLendon, B. A., & Cain, J. W. (2022) · Molecular Reproduction and Development · doi:10.1002/mrd.23570 · Cited by 48
Mitochondrial redox adaptations enable alternative aspartate synthesis in SDH-deficient cells
Hart, M. L., Quon, E., Vigil, A.-L. B. G., Engström, I., Newsom, O. J., Davidsen, K., Hoellerbauer, P., Carlisle, S. M., & Sullivan, L. B. (2023) · eLife · doi:10.7554/elife.78654 · Cited by 50
Self-citationKoritzinsky, M., & Wouters, B. G. (2013) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2013.05.006 · Cited by 50
Glutamine at focus: versatile roles in cancer
Vitto, H. D., Pérez-Valencia, J. A., & Radosevich, J. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-4671-9 · Cited by 54
Metabolic reprogramming in the pathogenesis of glioma: Update
Masui, K., Onizuka, H., Cavenee, W. K., Mischel, P. S., & Shibata, N. (2019) · Neuropathology · doi:10.1111/neup.12535 · Cited by 48
T cell-specific deletion of Pgam1 reveals a critical role for glycolysis in T cell responses
Toriyama, K., Kuwahara, M., Kondoh, H., Mikawa, T., Takemori, N., Konishi, A., Yorozuya, T., Yamada, T., Soga, T., Shiraishi, A., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01122-w · Cited by 51
Amino Acids in Cancer and Cachexia: An Integrated View
Ragni, M., Fornelli, C., Nisoli, E., & Penna, F. (2022) · Cancers · doi:10.3390/cancers14225691 · Cited by 48
Li, J., Zheng, C., Mai, Q., Huang, X., Pan, W., Lu, J., Chen, Z., Zhang, S., Zhang, C., Huang, H., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.002 · Cited by 48
Metadata
- Authors
- Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Northwestern University (US)
- National Institutes of Health (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Chandel, Navdeep S.
- DeBerardinis, Ralph J.
- ORCID
- Venue
- Nature
- Published
- 2011-11-20
- Volume
- 481
- Issue
- 7381
- Pages
- 385-388
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3262117
- OpenAlex
- W2092152920
- Cited by
- 1,328
- References
- 27
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 63 · 2023: 70 · 2022: 107 · 2021: 107 · 2020: 91 · 2019: 88 · 2018: 82 · 2017: 84 · 2016: 96 · 2015: 98 · 2014: 99 · 2013: 86 · 2012: 80
- FWCI
- 29.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA123067, R01CA157996, T32CA009560)
- National Institute of General Medical Sciences (T32GM083831, T32GM008061)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK072565, K01DK078933, DK078933)
- National Center for Research Resources (P41RR002584, RR‐02584)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- reductive carboxylation, glutamine metabolism, IDH1, acetyl-CoA, lipogenesis, hypoxia, tumor growth, fumarate hydratase deficiency, renal carcinoma, TCA cycle
- MeSH terms
- Acetyl Coenzyme A, Animals, Carcinoma, Renal Cell, Electron Transport, Fumarate Hydratase, Glucose, Glutamine, Humans, Isocitrate Dehydrogenase, Kidney Neoplasms, Mitochondria, NADP, Neoplasms, Electron Transport Complex III, Cell Hypoxia, Citric Acid, Electron Transport Complex I, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
